Abiopharma

New Form SCHEDULE 13G - METTLER TOLEDO INTERNATIONAL INC/ <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000849 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Moelis & Co <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000848 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - MFA FINANCIAL, INC. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000851 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - MKS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000852 <b>Size:</b> 7 KB

Approval was received from the Supervisor of Banks for the early redemption of subordinated notes (Series 10).

(30% Negative) MARCUS CORP (MCS) Reports Q2 2026 Financial Results

(75% Positive) CADRENAL THERAPEUTICS, INC. (CVKD) Provides Update on trial for heparin-induced thrombocytopenia (HIT)

New Form SCHEDULE 13G - Northwest Bancshares, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000833 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Marathon Petroleum Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000834 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - MILLER INDUSTRIES INC /TN/ <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000831 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - MCKESSON CORP <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000832 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - MARTIN MARIETTA MATERIALS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000830 <b>Size:</b> 7 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001918704-26-011516 <b>Size:</b> 282 KB

New Form SCHEDULE 13G - MID AMERICA APARTMENT COMMUNITIES INC. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000829 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Matson, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000828 <b>Size:</b> 7 KB